SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-003516
Filing Date
2017-06-06
Accepted
2017-06-06 17:10:14
Documents
1
Period of Report
2017-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060617.htm 8-K 23443
  Complete submission text file 0001171843-17-003516.txt   24716
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 17894856
SIC: 2834 Pharmaceutical Preparations